Wyeth (WYE)

CAPS Rating:

The Company is engaged in the discovery, development, manufacture, distribution and sale of a diversified line of products in three primary businesses: Pharmaceuticals, Consumer Healthcare and Animal Health.

View All Commentary (WYE)

Recs

0

Avatar deuspecuniae (26.19) Submitted: 5/01/08 12:11 PM : Start Price: $44.41 WYE Score: 20.31

The looming recession that bernanke and the whole federal reserve gang have set this country towards will send alot of investors into the pharmaceutical's sector--being the traditional recessionary savior to say the least. Plus, most pharmaceutical stocks have been beaten down this past winter, and I see a reversal across the entire sector. Also, those companies already on a run will continue due to the upward momentum this summer from key reversals and upgrades throughout the sector.

Report this Post Replies: 0 | Reply

Wyeth (WYE)

0

Featured Broker Partners